(Q72693309)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

N Feifel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

K Kucher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

L Fuchs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M Jedrychowski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

E Schmidt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

K H Antonin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P R Bieck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

C H Gleiter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

265-269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00315394

28 October 2019

exact match

0 references

cites work

Clinical Implications of the Competitive Inhibition of the Debrisoquin-Metabolizing Isozyme by Quinidine

1 reference

12 December 2020

Comparison of gas chromatographic and high-performance liquid chromatographic assays for the determination of debrisoquine and its 4-hydroxy metabolite in human fluids

1 reference

12 December 2020

Genetic Aspects of Drug Disposition and Therapeutics

1 reference

12 December 2020

Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine

1 reference

12 December 2020

Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6

1 reference

12 December 2020

Determination of the new monoamine oxidase inhibitor brofaromine and its major metabolite in biological material by gas chromatography with electron-capture detection

1 reference

12 December 2020

Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development

1 reference

12 December 2020

Protecting poor metabolizers, a group at high risk of adverse drug reactions

1 reference

12 December 2020

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

1 reference

12 December 2020

Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine

1 reference

12 December 2020

Relevance of genetic polymorphism in drug metabolism in the development of new drugs

1 reference

12 December 2020

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00315394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276052%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference